Abstract
Sublingual immunotherapy (SLIT) is safer than subcutaneous immunotherapy (SCIT) and this has lead to the reconsideration of the use of ultra-rush schedules for SLIT. The aim of this study was to assess the safety of ultra-rush SLIT in pollen-allergic children according to different timing of administration in relation to the pollen season.
Lingua originale | English |
---|---|
pagine (da-a) | 103-107 |
Numero di pagine | 5 |
Rivista | Current Medical Research and Opinion |
Volume | 25 |
Stato di pubblicazione | Published - 2009 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.2700.2700???